GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Darwin AG (XTER:7V0) » Definitions » Notes Receivable

Darwin AG (XTER:7V0) Notes Receivable : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Darwin AG Notes Receivable?

Darwin AG's Notes Receivable for the quarter that ended in Dec. 2024 was €0.00 Mil.


Darwin AG Notes Receivable Historical Data

The historical data trend for Darwin AG's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Darwin AG Notes Receivable Chart

Darwin AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Notes Receivable
- - - -

Darwin AG Semi-Annual Data
Dec21 Dec22 Dec23 Dec24
Notes Receivable - - - -

Darwin AG Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Darwin AG Notes Receivable Related Terms

Thank you for viewing the detailed overview of Darwin AG's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Darwin AG Business Description

Traded in Other Exchanges
Address
Brienner Strasse 7, Munich, BY, DEU, D-80333
Darwin AG is a biotechnology company. It is engaged in the field of human genetics. The group also develops and sells personalized dietary supplements and cosmetics. Its brand includes Novodaily; Rootine and Genopedia.

Darwin AG Headlines

No Headlines